E4 MedChem antivirals I Flashcards
(84 cards)
HSV-1
A. oral
B. genital
A
HSV-2
A. oral
B. genital
B
when can severe disease occur from CMV?
if infection occurs during fetal development
Acyclovir:
______ _______ derivative
acyclic guanosine
Acyclovir:
lacks _ _____
3’ hydroxyl
Acyclovir selectively accumulates in ________ cells.
this results in (higher/lower) conc.
infected, higher
Acyclovir requires _ phosphorylation events
3
Acyclovir MOA
competitive inhibitor of viral DNA polymerase
Acyclovir competes with _____
dGTP
T or F:
acyclovir is incorporated into DNA
true
Acyclovir acts as a _____ terminator
chain
Acyclovir is active against what 3 things
HSV-1, HSV-2, VZV
2 resistance mechanisms against acyclovir
mutations in viral thymidine kinase
mutations in viral DNA polymerase
Valacyclovir is an _______ ester of acyclovir
L-valyl (whatever tf this means)
Valacyclovir is rapidly converted to _________ by _________ in the intestine and liver
acyclovir, esterases
T or F:
Valacyclovir has improved efficacy compared to acyclovir for all indications
true frfr
valacyclovir is transported by ________ ________ ____ transporters
intestinal amino acid
Famciclovir is a prodrug of ______
penciclovir
How is famciclovir converted to penciclovir?
first pass metabolism in intestine and liver
MOA of famciclovir and penciclovir:
1. activated by ____ and cellular _________
2. competitive inhibitor of viral ____ _________
3. Does NOT cause immediate _______ __________
- viral, kinases
- dna polymerase
- chain termination
T or F:
Viral kinase mutants confer cross-resistance to penciclovir and acyclovir
true
T or F:
acyclovir has a higher affinity for HSV TK than penciclovir
false, other way around
T or F:
levels of penciclovir triphos in infected cells are higher than the levels of acyclovir triphos
true
T or F:
HSV DNA polymerases have a higher affinity for acyclovir triphos than for penciclovir
true